Compare MSGY & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSGY | ECOR |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5M | 39.6M |
| IPO Year | 2025 | 2018 |
| Metric | MSGY | ECOR |
|---|---|---|
| Price | $2.70 | $4.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $25.50 |
| AVG Volume (30 Days) | ★ 650.6K | 36.3K |
| Earning Date | 12-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | $23,318,482.00 | ★ $29,835,000.00 |
| Revenue This Year | N/A | $28.61 |
| Revenue Next Year | N/A | $41.21 |
| P/E Ratio | $25.82 | ★ N/A |
| Revenue Growth | 13.04 | ★ 27.90 |
| 52 Week Low | $0.83 | $4.16 |
| 52 Week High | $22.20 | $19.49 |
| Indicator | MSGY | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.56 |
| Support Level | N/A | $4.41 |
| Resistance Level | N/A | $4.99 |
| Average True Range (ATR) | 0.00 | 0.25 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 61.76 |
Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.